why choose us

First received: July 24, 2023

Clinical Trial: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-Alcoholic Steatohepatitis (NASH)

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)

Brief Summary: Purpose of this study is to assess the effects of pemvidutide on NASH resolution and NASH fibrosis.

Read more